Massive growth from COVID testing is hiding an excellent business.
News & Analysis: Fulgent Genetics, Inc.
Here's why Fulgent stock is running so high.
It's a volatile stock right now. But the future for genomic testing looks bright.
The genetic testing services specialist has been on a tear.
The long-term prospects for this high-flying stock appear to be very good.
After a stellar 2020, the genetic testing specialist is starting off this year with a bang.
There are two simple reasons.
Both of these businesses prospered even during a volatile year -- and the coming months could be even more impressive.
These winners are positioned for gains even after COVID.
A Wall Street analyst downgraded the genetics testing provider.